Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice.
Hulin C, de la Rubia J, Dimopoulos MA, Terpos E, Katodritou E, Hungria V, De Samblanx H, Stoppa AM, Aagesen J, Sargin D, Sioni A, Belch A, Diels J, Olie RA, Robinson D Jr, Potamianou A, van de Velde H, Delforge M. Hulin C, et al. Among authors: dimopoulos ma. Health Sci Rep. 2018 Dec 7;2(1):e104. doi: 10.1002/hsr2.104. eCollection 2019 Jan. Health Sci Rep. 2018. PMID: 30697597 Free PMC article.
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice.
Terpos E, Katodritou E, de la Rubia J, Hungria V, Hulin C, Roussou M, Delforge M, Bries G, Stoppa AM, Aagesen J, Sargin D, Belch A, Ahlberg L, Diels J, Olie RA, Robinson D Jr, Spencer M, Potamianou A, van de Velde H, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Eur J Haematol. 2018 Oct;101(4):556-565. doi: 10.1111/ejh.13147. Epub 2018 Sep 5. Eur J Haematol. 2018. PMID: 30027641 Clinical Trial.
Advances in the treatment of multiple myeloma.
Dimopoulos MA, Terpos E. Dimopoulos MA, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S306-8. doi: 10.1016/S0959-8049(11)70181-2. Eur J Cancer. 2011. PMID: 21943993 No abstract available.
Current treatments for renal failure due to multiple myeloma.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Expert Opin Pharmacother. 2013 Aug;14(11):1477-95. doi: 10.1517/14656566.2013.803068. Epub 2013 May 25. Expert Opin Pharmacother. 2013. PMID: 23705905 Review.
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma.
Dimopoulos MA, Orlowski RZ, Facon T, Sonneveld P, Anderson KC, Beksac M, Benboubker L, Roddie H, Potamianou A, Couturier C, Feng H, Ataman O, van de Velde H, Richardson PG. Dimopoulos MA, et al. Haematologica. 2015 Jan;100(1):100-6. doi: 10.3324/haematol.2014.112037. Epub 2014 Sep 26. Haematologica. 2015. PMID: 25261096 Free PMC article.
Emerging antibodies for the treatment of multiple myeloma.
Zagouri F, Terpos E, Kastritis E, Dimopoulos MA. Zagouri F, et al. Among authors: dimopoulos ma. Expert Opin Emerg Drugs. 2016 Jun;21(2):225-37. doi: 10.1080/14728214.2016.1186644. Expert Opin Emerg Drugs. 2016. PMID: 27195659 Review.
Current treatments for renal failure due to multiple myeloma.
Gavriatopoulou M, Terpos E, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Expert Opin Pharmacother. 2016 Nov;17(16):2165-2177. doi: 10.1080/14656566.2016.1236915. Epub 2016 Sep 27. Expert Opin Pharmacother. 2016. PMID: 27646819 Review.
1,298 results